Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer
Status:
Active, not recruiting
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well cabozantinib s-malate works in treating patients with
endometrial cancer that has come back (recurrent) or has spread to other places in the body
(metastatic). Cabozantinib s-malate may stop the growth of tumor cells by blocking some of
the enzymes needed for cell growth and by blocking blood flow to the tumor.